Sarissa Capital Management LP Jazz Pharmaceuticals PLC Transaction History

Sarissa Capital Management LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$128.64 - $184.79 $128,639 - $184,790	-1,000 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$150.19 - $173.5 $139 Million - $161 Million	-927,100 Reduced 99.89%	1,000 $164,000
Q2 2020 Aug 14, 2020	BUY	$95.68 - $121.88 $15.6 Million - $19.9 Million	163,100 Added 21.32%	928,100 $102 Million
Q1 2020 May 15, 2020	BUY	$87.74 - $152.74 $28.2 Million - $49.1 Million	321,500 Added 72.49%	765,000 $76.3 Million
Q4 2019 Feb 14, 2020	BUY	$117.65 - $153.73 $23.7 Million - $31 Million	201,500 Added 83.26%	443,500 $66.2 Million
Q3 2019 Nov 14, 2019	BUY	$125.18 - $143.24 $5.7 Million - $6.52 Million	45,500 Added 23.16%	242,000 $31 Million
Q2 2019 Aug 14, 2019	BUY	$125.55 - $144.48 $12.1 Million - $13.9 Million	96,500 Added 96.5%	196,500 $28 Million
Q1 2019 May 15, 2019	BUY	$121.81 - $142.95 $12.2 Million - $14.3 Million	100,000 New	100,000 $14.3 Million

511

57.7M

188K

133K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.47B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Sarissa Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Sarissa Capital Management LP with notifications on news.